IMAJ | volume 25
Journal 9, September 2023
pages: 612-616
1 Department of Surgery C, Sheba Medical Center, Tel Hashomer, Israel
2 Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3 Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
Summary
Background:
Long-term outcome data for bariatric surgery in patients with severe obesity (SO) (body mass index [BMI] ³ 50 kg/m
2) are scarce.
Objectives:
To compare perioperative morbidity and long-term outcomes between patients with SO and non-SO (NSO).
Methods:
Patients with SO who underwent primary bariatric surgery with a follow-up ³ 5 years were age- and gender-matched with NSO patients in a retrospective, case-control study. Data included demographics, BMI, co-morbidities, early outcomes, current and nadir weight, co-morbidity status, and general satisfaction.
Results:
Of 178 patients, 49.4% were male, mean age 44.5 ± 14 years. Mean preoperative BMI was 54.7 ± 3.6 and 41.8 ± 3.8 kg/m
2 in SO and NSO, respectively (
P = 0.02). Groups were similar in preoperative characteristics. Depression/anxiety was more prevalent in NSO (12.4% vs. 3.4%,
P = 0.03). Obstructive sleep apnea was higher in SO (21.3% vs. 10.1%,
P = 0.04). Sleeve gastrectomy was performed most often (80.9%), with a tendency toward bypass in SO (
P = 0.05). Early complication rates were: 13.5% in SO and 12.4% in NSO (
P = 0.82). Mean follow-up was 80.4 ± 13.3 months. BMI reduction was higher in SO (31.8 ± 5.9 vs. 26.8 ± 4.2 kg/m
2,
P < 0.001) and time to nadir weight was longer (22.1 ± 21.3 vs. 13.0 ± 12.0 months,
P = 0.001). Co-morbidity improvement and satisfaction were similar.
Conclusions:
Patients with SO benefited from bariatric surgery with reduced BMI and fewer co-morbidities. No added risk of operative complications was found compared to patients with NSO.